Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Any use outside a controlled laboratory research setting is unauthorized
The preclinical and clinical literature strongly support trimetazidines potential to treat bipolar depression, having anti-inflammatory and antioxidant properties while normalizing mitochondrial function only when it is compromised
Reported side effects in limited human use include mild nausea and dizziness
There is no need to reduce either dose when combining
AHK-Cu has been studied more directly in relation to human hair follicles and dermal papilla cells
US$ 27.18
US$ 20.75
US$ 24.41
